Advertisement

Topics

Companies Related to "Association Study Postoperative Cognitive Dysfunction Associated With Inflammation Polymorphism" [Most Relevant Company Matches] RSS

16:04 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Association Study Postoperative Cognitive Dysfunction Associated With Inflammation Polymorphism" found in our extensive corporate database of over 50,000 company records.

Showing "Association Study Postoperative Cognitive Dysfunction Associated With Inflammation" Companies 1–25 of 2,500+

Relevant

Saegis Pharmaceuticals, Inc

Saegis is a development-stage company focused on the discovery of drugs to address behavioral disorders. Saegis has clinically evaluated three small molecule drugs and has a growing pipeline of novel treatments for central nervous system (CNS) diseases involving cognitive dysfunction.The company's focus is on Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Cognitive Impairment Associate...


Cognitive Scale

Cognitive Scale powers standards-based Cognitive CloudsTM, which are revolutionizing big data and analytics markets. Cognitive CloudsTM are a new class of data interpretation and learning systems that weave cognitive intelligence into business processes and applications. They work on massive amounts of multi structured data including text, images and video...

Neurotrack

Neurotrack is a digital health company dedicated to the development of non-invasive cognitive health assessment tools that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline, and help advance research of treatments for cognitive diseases, including Alzheimer's. The test is intended to be used by clinician...


CognitiveScale

CognitiveScale powers standards-based cognitive clouds, which are revolutionizing big data and analytics markets. Cognitive clouds are a new class of data interpretation and learning systems that weave cognitive intelligence into business processes and applications. They work on massive amounts of multi structured data including text, images and video t...

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

Accelerated Cure Project for Multiple Sclerosis

MS is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the United States and two million individuals worldwide. The disorder occurs twice as often in wom...

Cognitive Science Society

The Cognitive Science Society, Inc. is a non-profit professional organization that brings together researchers from many fields who hold a common goal: understanding the nature of the human mind. The Society promotes scientific interchange among researchers in disciplines comprising the field of Cognitive Science, including Artificial Intelligence, Linguistics, Anthropology, Psychology, Neuroscien...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Population Association of America (PAA)

The Population Association of America (PAA) is a nonprofit, scientific, professional organization established in 1930 to support the scientific study of the human population. PAA is an organization of professionals from multiple disciplines including demographers, sociologists, economists, public health professionals, and other engaged in resea...

Synedgen Inc.

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree and to reduce damage and inflammation due to chemical, radiological or physical damage using the science of glycomics - the study of complex sugar structure and function. Synedgen ...

Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (http://www.alzdiscovery.org/) is the only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and cure Alzheimer's disease and cognitive aging. An affiliated public charity of the Institute for the Study of Aging (ISOA), a private foundation established by the Estee Lauder family in 1998, ADDF was established in 2004...

Quartet Medicine

Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation. Quartet is capitalizing on these ...

Targacept, Inc.

Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, a unique class of proteins that regulate vital biological functions that are impaired in various disease states. Tar...

International Association for the Study of Pain

European Association for the Study of the Liver

American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD)

International Association for the Study of Traditional Asian Medicine

NeuroMedix

NeuroMedix is a pharmaceutical company focused on the development of therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. Our therapeutic candidates are based on research from a team of leading experts in the field of neuroinflammation.In pre-clinical studies, our candidates have proven to ...

Cognitive Clinical Trials

Cognitive Clinical Trials (CCT) is a company offering an innovative approach to conducting clinical research for the prevention and treatment of Alzheimer’s Disease. CCT embeds research facilities in senior living communities, which simplifies the process for patients and provides sponsors with high quality data. For more information, visit www.cctresearch.c...

Brain Health Registry

The Brain Health Registry (BHR) is a groundbreaking free, online platform designed to speed the path to cures for Alzheimer’s, Parkinson's, depression, PTSD, mild cognitive impairment and other brain disorders. BHR gathers cognitive data from volunteers who have registered and completed questionnaires and cognitive tests on the BHR website. BHR aim...

The CFIDS Association of America

The CFIDS Association of America reiterates its long-standing recommendation urging that individuals with CFS voluntarily not donate blood or organs. This recommendation is based on issues of blood donor safety and blood recipient safety. Research has demonstrated that orthostatic intolerance, low blood volume and infections are common in CFS. Until more i...

American Chiropractic Association

The American Chiropractic Association (ACA), based in Arlington, Va., is the largest professional association in the United States representing doctors of chiropractic. ACA promotes the highest standards of ethics and patient care, contributing to the health and well-being of millions of chiropractic patients. On behalf of its members, ACA lobbies for pro-chiropractic legislation and policies, ...

Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept’s product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targace...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test Automated Battery. The cognitive tests in CANTAB are used for neuropsychological assessment in academic research, pharmaceutical clinical trials and healthcare around the world.


More From BioPortfolio on "Association Study Postoperative Cognitive Dysfunction Associated With Inflammation Polymorphism"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks